Freed Associates

Freed Consultant, Chet Stagnaro, Quoted in Bloomberg Article on Blockchain Use in Pharmaceuticals.

According to Bloomberg, blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business…“The best bet going right now appears to be blockchain,” in part because of the shortcomings of conventional software, said Chet Stagnaro, a consultant with health-care advisory firm Freed Associates. “The potential is definitely there.”

Read more: Bloomberg article.